National Tuberculosis Control Program Activities of Turkey

Similar documents
Dr Malgosia Grzemska Global TB programme, WHO/HQ Meeting of manufacturers Copenhagen, Denmark, November 2015

Management of Tuberculosis: Indian Guidelines

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Recent Advances in The Treatment of Mycobacterium Tuberculosis

Guideline. Treatment of tuberculosis in pregnant women and newborn infants. Version 3.0

Emerging Infectious Disease (4): Drug-Resistant Tuberculosis

M I L L I O N S Figure 2.1 Number of people newly infected with HIV

Drug-resistant Tuberculosis

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health

The Role of the Health Service Administrator in TB Control. National Tuberculosis Control Programme

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

Guideline. Treatment of tuberculosis in renal disease. Version 3.0

Pregnancy and Tuberculosis. Information for clinicians

MODULE THREE TB Treatment. Treatment Action Group TB/HIV Advocacy Toolkit

General Information on Tuberculosis

Draft Law on Public Health

Part 4 Burden of disease: DALYs

No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

Components of a good surveillance system and future plans for improvement in the EMR

Pediatric Latent TB Diagnosis and Treatment

Guidance on how to measure contributions of public-private mix to TB control

AMBULATORY TREATMENT AND PUBLIC HEALTH MEASURES FOR A PATIENT WITH UNCOMPLICATED PULMONARY TUBERCULOSIS

annex 2 country profiles

Treatment of TB a pharmacy perspective

Treatment of tuberculosis. guidelines. Fourth edition

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention

Programme «Allocations de recherche pour une thèse au Sud (ARTS)» ARTS program

Tuberculosis in Myanmar Progress, Plans and Challenges

Technical guidance note for Global Fund HIV proposals in Round 11

Revised National Tuberculosis Control Programme (RNTCP) Dr. NAVPREET

AMBULATORY TREATMENT AND PUBLIC HEALTH MEASURES FOR A PATIENT WITH UNCOMPLICATED PULMONARY TUBERCULOSIS

DIRECTLY OBSERVED TREATMENT SHORT-COURSE (DOTS)

Chapter Four: Treatment of Tuberculosis Disease

Tuberculosis in Children and Adolescents

MANAGEMENT OF TUBERCULOSIS IN PRISONS: Guidance for prison healthcare teams

TREATING DRUG-SENSITIVE TB IN INDIA: IMPLEMENTATION OF DAILY THERAPY WITH FIXED DOSE COMBINATIONS

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

What you will study on the MPH Master of Public Health (online)

Self-Study Modules on Tuberculosis

FY2014 Senate Labor-HHS-Education Bill Summary

Tuberculosis in children in Europe -the ptbnet

Age In London TB is more common in younger adults aged years and peaks in the age group (3).

Tuberculousmeningitis: what is the best treatment regimen?

TUBERCULOSIS CONTROL INDIA

Analysis of the Global TB Drug Market and Country-Specific Case Studies of TB Drug Distribution Channels

Current trends in chemotherapy of tuberculosis

Santa Clara County Tuberculosis Screening Requirement for School Entrance Effective June 1, Frequently Asked Questions

Tuberculosis. TB the disease, its treatment and prevention

TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY. Stephanie N. Lin MD 2/12/2016

Dennis FALZON. TB surveillance and surveys: A training workshop for consultants. Geneva, Switzerland - 26 May 2011

MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS POLICY GUIDELINES

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Master of Public Health (MPH) SC 542

Definitions and reporting framework for tuberculosis 2013 revision (updated December 2014)

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

Health, history and hard choices: Funding dilemmas in a fast-changing world

NOTICE OF PUBLIC HEARING REGARDING PROPOSED CHANGES IN HEALTH CARE SERVICES PROVIDED BY FRESNO COUNTY

Tuberculosis and You A Guide to Tuberculosis Treatment and Services

WHO in 60 years: a chronology of public health milestones

TREATMENT OF TUBERCULOSIS: GUIDELINES FOR NATIONAL PROGRAMMES THIRD EDITION

INTEGRATED CLINICAL SYSTEMS MANAGEMENT QUALITY IMPROVEMENT OF CARE OF PLWHA

REPUBLIC OF UGANDA UGANDA NATIONAL GUIDELINES FOR THE PROGRAMMATIC MANAGEMENT OF DRUG RESISTANT TUBERCULOSIS

Appendix B: Provincial Case Definitions for Reportable Diseases

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

Ministry of Public Health and Sanitation GUIDELINES FOR THE MANAGEMENT DRUG RESISTANT TUBERCULOSIS IN KENYA

THE ORGANISATION AND FINANCING OF HEALTH CARE SYSTEM IN LATVIA

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

Chapter 6 Treatment of Tuberculosis Disease

SYLLABUS. Path-217. Haneline MT, Meeker WC. Introduction to Public Health for Chiropractors. Sudbury, MA: Jones and Bartlett Publishers, 2011.

COMMUNICABLE DISEASE

The Healthy Asia Pacific 2020 Roadmap INTRODUCTION: THE HEALTHY ASIA PACIFIC 2020 INITIATIVE

Guideline. Treatment of tuberculosis in adults and children Version 2.1 July 2015

MANAGEMENT OF TUBERCULOSIS

Drug-Resistant Tuberculosis: Old Disease New Threat (April 2013)

Diabetes. Gojka Roglic. Department of Chronic Diseases and Health Promotion. World Health Organization

Tuberculosis OUR MISSION THE OPPORTUNITY

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Treatment. Introduction Individualized Regimens Selection and Dosing of Drugs Administration of the Regimen...

Threats and Opportunities the Scientific Challenges of the 21 st Century

RESEARCH AGENDA ON DRUG RESISTANT TUBERCULOSIS With A Focus On Scaling-up Programmes

Dublin Declaration. on Partnership to fight HIV/AIDS in Europe and Central Asia

Epidemics emergency: what role for research?

Manual on use of routine data quality assessment (RDQA) tool for TB monitoring. World Health Organization Stop TB Department, Geneva

Resources for the Prevention and Treatment of Substance Use Disorders

Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

Strengthening Policies on the Harmful Use of Alcohol, Gender-Based Violence and Infectious Disease

Targeted Testing for Tuberculosis Infection

Costs of inpatient treatment for multi-drug resistant tuberculosis in South Africa

Office ID Location: City State Date / / PRIMARY CARE SURVEY

IMA Knowledge June, 2015

Ginny Dowell, RN, BSN October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

Questions and Answers About Tuberculosis

GUIDELINES FOR TUBERCULOSIS PREVENTIVE THERAPY AMONG HIV INFECTED INDIVIDUALS IN SOUTH AFRICA

Research Opportunities & Priorities: WHO/EMRO. Cost Effectiveness Workshop 14 th December, 2014

Self-Study Modules on Tuberculosis

Summary of the risk management plan (RMP) for Sirturo (bedaquiline)

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0

Transcription:

National Tuberculosis Control Program Activities of Turkey Dr. Seher MUSAONBASIOGLU Public Health Institution of Turkey Head of Tuberculosis Department December, 2013

The Central Organization Structure of Ministry of Health

Public Health Institution of Turkey PRESIDENT LEGAL ADVISORY AUDIT SERVICES DEPARTMENT PRESIDENTIAL OFFICE STRATEGY DEVELOPMENT DEPARTMENT VICE PRESIDENT VICE PRESIDENT VICE PRESIDENT VICE PRESIDENT VICE PRESIDENT PRIMARY HEALTH CARE SERVICES COMMUNICABLE DISEASE CONTROL PROGRAMS NON COMMUNICABLE DISEASES AND CANCER DEPARTMENT CONSUMER AND EMPLOYMENT SECURITY SUPPORT SERVICES DEPARTMENT FAMILY MEDICINE PRACTICE MONITORING AND EVALUATION FAMILY MEDICINE TRAINING AND DEVELOPMENT FAMILY MEDICINE COMMUNITY HEALTH SERVICES PRIMARY HEALTH CARE DEPARTMENT OF PLANNING AND ORGANIZATION EARLY WARNING AND REPLY FIELD EPIDEMIOLOGY DEPARTMENT INFECTIOUS DISEASES VACCINE-PREVENTABLE DISEASES ZOONOTİC AND VECTORİAL DISEASES TUBERCULOSIS MICROBIOLOGY REFERENCE LABORATORIES CANCER ADDICTIVE SUBSTANCE AGAINST TOBACCO AND OTHER DEPARTMENT MENTAL HEALTH PROGRAMS OBESİTY, DİABETES AND METABOLİC DİSEASES DEPARTMENT CHRONIC DISEASES, THE ELDERLY AND HANDICAPPED HEALTH WOMEN AND REPRODUCTIVE HEALTH DEPARTMENT CHILD AND ADOLESCENT HEALTH DEPARTMENT EMPLOYEE HEALTH AND SAFETY DEPARTMENT ENVIRONMENTAL HEALTH DEPARTMENT CONSUMER AND EMPLOYMENT SECURITY LABORATORY PUBLIC HEALTH LABORATORY BIOLOGICAL PRODUCTS RESEARCH AND DEVELOPMENT APPOINTMENT PERSONNEL AFFAIRS DEPARTMENT REVOLVING FUND MANAGEMENT DEPARTMENT PURCHASING AND ADMINISTRATIVE AFFAIRS DEPARTMENT STATISTICS AND DATA PROCESSING

Organizational Structure of Public Health Directorates

Tuberculosis Department Tuberculosis Department is the central unit of tuberculosis control in Turkey. Tuberculosis Department is structured under The Public Health Institute Vice Presidency of Communicable Disease Control Programmes and responsible from the creation and implementation of National Tuberculosis Control Program The Units of Tuberculosis Department Epidemiological Surveillance and Statistics Section Monitoring, Evaluation and Projects Intersectoral Collaboration and Education Field Services and Drug Supply Multi-Drug Resistant Tuberculosis Patient Management

Components of the National Tuberculosis Control Programme Political commitment Quality controlled bacteriological examination to find cases Supervised practice and patient-centered Directly Observed Treatment (DOT) Effective drug supply and management system Monitoring and evaluation with reporting system Multi-Drug Resistant TB, TB / HIV association and highlighting the problems of other risk groups To ensure the participation of the all parties of health service providers to fight TB To increase the participation of tuberculosis patients and society in TB fight To support the scientific researches related to tuberculosis

Estimated TB Incidence Rates, 2012 (WHO 2013 Global TB Control Report) Incidence Rate of Turkey: 22 per 100 000 population

WHO Global TB Report 2013 Data Estimated TB Disease Burdens, 2012 (in one hundred thousand population) REGION Mortality Rate Prevalence Rate Incidence Rate Africa 26 303 255 Americas 1,9 40 29 Eastern Mediterranean 16 180 109 Europe 3,9 56 40 * TURKEY 0,52 23 22 South East Asia 25 264 187 Western Pacific 5,8 128 87 GLOBAL 13 169 122

WHO Global TB Report 2013 Data TB Case Detection Rates and Treatment Success Rates REGION Case Detection Rate (%) (2012) Treatment Success Rate in New Smear (+) Pulmonary Cases (%) (2011) Treatment Success Rate in Retreatment Cases (%) (2011) Africa 59 82 68 Americas 79 78 51 Eastern Mediterranean 63 88 74 Europe 79 66 47 * TURKEY 87 90 68 South East Asia 62 89 75 Western Pacific 85 94 86 GLOBAL 67 87 72

TB Data of Turkey for 2012 year, Patient Numbers The number of all TB cases: 14.691 New cases 13.535 %92 Retreatment cases 1.156 %8 Total cases 14.691 Male 8.727 %59 Female 5.964 %41 Pulmonary TB cases 9.391 %64 Extrapulmonary TB cases 5.300 %36

TB Dispensaries (December 2013) TB Dispensaries: 177

Mobile Screening Teams

Distribution of TB Laboratories Laboratory Level Number % TB Dispensary Lab 97 25,1 State Hospital 87 22,5 Faculty of Medicine 60 15,5 Private Hospital 41 10,6 Traning Hospitals 36 9,3 Private Lab 22 5,7 Regional TB Lab 20 5,2 Chest Diseases Hospital 10 2,6 Private Medical Center 3 0,8 Public Health Laboraory 2 0,5 NTRL 1 0,3 Other 7 1,8 TOTAL 386 100,0

Multi-Drug Resistant TB Cases Numbers of MDR-TB Cases, 2005-2012 Numbers of cases 350 300 250 200 150 100 50 191 90 101 249 240 263 118 120 138 131 120 125 222 123 99 250 262 140 146 110 116 291 151 140 0 2005 2006 2007 2008 2009 2010 2011 2012 Year New Cases Retreatment Cases All Cases

Multi-Drug Resistant TB Cases, 2012

Electronic Tuberculosis Management System By the aim of improving data quality and integrity, ensuring the real-time monitoring and evaluation of the program and so in order to strengthen the National Tuberculosis Control Program, Electronic Tuberculosis Management System has been established The diagnosis, treatment, monitoring and reporting procedures of TB patients can be followed up using the internet with this system until March 2012 Tüberküloz Daire Başkanlığı

Elektronik Tüberküloz Yönetim Sistemi (e-tys) Tüberküloz Daire Başkanlığı

Drug Supply Activities Antituberculosis medicines of TB patients registered in TB dispensaries are purchased and distributed free by the Ministry The distribution of antituberculosis drugs of MDR-TB patients (2nd choice tuberculosis medication) are carried out by The Ministry from January 2008 in a continuous, safe and quick way Antituberculosis drugs were started to be distributed via purchasing by the Presidency to I, II. and III. level health care institutions and organizations for TB patients and contacts whether or not they have any social security in accordance with the decision of Cabinet published in the 05/08/2010 dated Official Journal. So the scope and nature of the distribution of tuberculosis drugs are expanded Social Security Institution does not pay the bill of prescriptions diagnosed with TB no longer in Turkey

Drug Supply Activities Maintenance of Drugs Standard TB Drugs (FREE) ISONIAZID 100 Mg TABLET ISONIAZID 300 Mg TABLET PYRAZINAMIDE 500 Mg TABLET ETHAMBUTOL 500 Mg TABLET RIFAMPICIN 150 Mg KAPSÜL RIFAMPICIN 300 Mg KAPSÜL RIFAMPICIN SÜSPANSİYON STREPTOMYCIN FLAKON MDR-TB Drugs (FREE) OFLOXACIN 200 Mg. TABLET MOXIFLOXACIN 400 Mg TABLET PARAAMİNOSALICYLIC ACID 1 Gr THIOACETAZONE 150 MG TABLET CAPREOMYSIN 1 GR.FLAKON CLOFAZIMINE 100 MG. KAPSÜL CYCLOSERINE 250 MG KAPSÜL PROTIONAMIDE 250 Mg. TABLET AMIKACIN 500 Mg. FLAKON LINEZOLID 600 Mg TABLET LINEZOLID 2 Mg/ml 300 ml inf. solution

Drug Supply Services General Distribution The demands of public health directorates are sent in quarterly. Patient-Based Distribution Second option drugs in patients who have received a diagnosis of MDR/ XDR TB when requested by the Agency regarding dispensaries are sent by courier from the Presidency. In demand that do qualify as specialized agencies of the Ministry; chest diseases and thoracic surgery training and research hospitals, the university hospitals report issued by the drug use must have.

Thanks